Literature DB >> 8603556

Surgery for local recurrence of rectal carcinoma.

T Wiggers1, M R de Vries, B Veeze-Kuypers.   

Abstract

PURPOSE: This study was designed to evaluate results, especially mortality and morbidity, of surgical resection with curative intent for patients with a local recurrence of rectal cancer, in combination with radiotherapy.
METHODS: Consecutive medical records of 163 patients with local recurrence of rectal carcinoma after previous "curative" therapy for primary rectal cancer were reviewed. Although 35 patients had an exploratory laparotomy, only 27 had local recurrence amendable to resection (6 irresectable locoregional recurrences and 2 distant metastases found at laparotomy). Twenty-one patients received radiotherapy. There was no perioperative mortality. Median follow-up time was 42 (range, 22-92) months.
RESULTS: Local recurrence occurred in 16 (59 percent) patients. Ten patients are alive, of whom nine have good local control. Estimated five-year survival (Kaplan-Meier) is 20 percent. Survival was significantly better in patients without a second recurrence, but radicality of the resection was not influential. Good local control could be obtained in 12 (44 percent) patients, and 1 patient is living with symptoms.
CONCLUSIONS: In selected patients with local recurrence of rectal carcinoma, reoperation with irradiation may result in good palliation and possibly cure.

Entities:  

Mesh:

Year:  1996        PMID: 8603556     DOI: 10.1007/bf02049476

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

1.  Reresection for local recurrence of rectal cancer.

Authors:  W Adachi; A Nishio; H Watanabe; J Igarashi; K Yazawa; Y Nimura; N Koide; A Matsushita; T Monma; K Hanazaki; S Kajikawa; J Amano
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003.

Authors:  Antonio Chiappa; Roberto Biffi; Andrew P Zbar; Fabrizio Luca; Cristiano Crotti; Emilio Bertani; Francesca Biella; Giulia Zampino; Roberto Orecchia; Nicola Fazio; Marco Venturino; Cristiano Crosta; Gian Carlo Pruneri; Carmine Grassi; Bruno Andreoni
Journal:  Int J Colorectal Dis       Date:  2004-12-16       Impact factor: 2.571

3.  Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience.

Authors:  Paulus Schurr; Edda Lentz; Suzette Block; Jussuf Kaifi; Helge Kleinhans; Guellue Cataldegirmen; Asad Kutup; Claus Schneider; Tim Strate; Emre Yekebas; Jakob Izbicki
Journal:  J Gastrointest Surg       Date:  2008-04-30       Impact factor: 3.452

4.  Adjuvant versus neoadjuvant chemoradiotherapy in distal rectal cancer: Comparison of two decades in a single center.

Authors:  Baha Zengel; Adam Uslu; Zehra Adıbelli; Halit Yetiş; Fevzi Cengiz; Ahmet Aykas; Cenk Şimşek; Göksever Akpınar; Nuket Eliyatkın; Ali Duran
Journal:  Ulus Cerrahi Derg       Date:  2015-12-01

5.  The Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma.

Authors:  Owen J O'Connor; Shanaugh McDermott; James Slattery; Dushyant Sahani; Michael A Blake
Journal:  Int J Surg Oncol       Date:  2011-07-03

6.  The radiosensitizing effect of doranidazole on human colorectal cancer cells exposed to high doses of irradiation.

Authors:  Li Zhang; Aimin Gong; Jun Ji; Yuanyuan Wu; Xiaoyu Zhu; Suqing Lv; Hongzhu Lv; Xizhuo Sun
Journal:  BMC Cancer       Date:  2007-10-06       Impact factor: 4.430

7.  Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

Authors:  Raphaëla C Dresen; Marleen J Gosens; Hendrik Martijn; Grard A Nieuwenhuijzen; Geert-Jan Creemers; Alette W Daniels-Gooszen; Adriaan J van den Brule; Hetty A van den Berg; Harm J Rutten
Journal:  Ann Surg Oncol       Date:  2008-04-04       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.